9. Biostatistics and Research Methodology
Learning Objectives
- Distinguish between descriptive and inferential statistics and apply each in a pharmacy context
- Explain the steps of the research process from hypothesis formulation to conclusion
- Identify appropriate study designs for different pharmaceutical research questions
- Interpret p-values, confidence intervals, and effect sizes in clinical trial reports
- Recognize the role of biostatistics in drug approval, bioequivalence, and pharmacoeconomics
- Apply ethical principles governing human subjects research in pharmacy settings
Quick Answer
Biostatistics and research methodology form the scientific backbone of pharmacy practice. Biostatistics provides the tools — descriptive summaries, hypothesis tests, regression models — that turn raw experimental data into actionable conclusions about drug efficacy and safety. Research methodology supplies the framework: how to design a study, control for bias, select a sample, and satisfy regulatory and ethical standards. Together they underpin every stage from early drug discovery through FDA approval, and they are heavily tested on the NAPLEX and pharmacy licensing exams. A pharmacist who cannot critically read a clinical trial report cannot practice evidence-based care.
Topics at a Glance
| Topic | Core Focus | Why It Matters |
|---|---|---|
| Biostatistics for Pharmacy | Descriptive stats, inferential tests, study design, software tools | Foundation for reading and interpreting research |
| Research Methodology in Pharmaceutical Sciences | Research process, study types, ethics, statistical methods | Framework for designing and evaluating studies |
| Clinical Research Methods | Statistical concepts applied in practice, research design in pharmacy | Bridges theory to real clinical trial interpretation |
Key Terms
| Term | Definition | Related Concept |
|---|---|---|
| Biostatistics | Application of statistical methods to biological and medical data | Inferential statistics, study design |
| Hypothesis testing | Statistical procedure to evaluate a claim about a population parameter | Null hypothesis, p-value |
| Confidence interval | Range of values likely to contain the true population parameter at a given confidence level | Inferential statistics, sample size |
| Randomized controlled trial (RCT) | Experimental study in which participants are randomly assigned to treatment or control groups | Phase III trials, bias control |
| P-value | Probability of obtaining results as extreme as observed, assuming the null hypothesis is true | Hypothesis testing, significance |
| Descriptive statistics | Summary measures (mean, median, SD) that describe the basic features of a dataset | Central tendency, variability |
| Bioequivalence | Demonstration that a generic drug delivers the same active ingredient at the same rate and extent as the reference product | FDA approval, ANDA |
| IRB (Institutional Review Board) | Committee that reviews and approves research protocols to protect human subjects | Ethics, informed consent |
Related Topics
Prerequisites: Basic mathematics and algebra; Pharmacokinetics fundamentals; Introduction to Pharmacy Practice
Related Topics: Pharmacoepidemiology; Evidence-Based Medicine; Pharmacoeconomics; Drug Information Resources
Next Topics: Clinical Pharmacology; Pharmacy Law and Regulation; Therapeutics and Drug Therapy Management